ロード中...
Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients
Introduction: High-risk patients with grade 3 endometrioid endometrial carcinoma (G3EEC) who require adjuvant therapy have not been clearly identified. Therefore, the current study aimed to investigate the prognostic impact of ARID1A, p53, and mismatch repair (MMR) protein expressions, previously re...
保存先:
| 出版年: | Pathol Oncol Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8262237/ https://ncbi.nlm.nih.gov/pubmed/34257552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/pore.2021.598550 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|